Abstract:There is an inherited susceptibility to polycystic ovary syndrome (PCOS). Some investigators have suggested that premature male-pattern balding is a male phenotype in PCOS families, but this remains controversial. We recently reported evidence for an autosomal monogenic abnormality in ovarian and adrenal steroidogenesis in the sisters of women with PCOS. We performed this study to determine whether we could identify a clinical or biochemical phenotype in the brothers of women with PCOS. One hundred nineteen br… Show more
“…It was also noted that brothers of the patients with PCOS had increased levels of DHEAS when compared with age matched controls. [13] Fathers of adolescent girls have a very high incidence of obesity (94%) and metabolic syndrome (79%). Also, mothers of such patients tend to be obese (54.4%) or overweight (11.4%) with the incidence of metabolic syndrome being 34%.…”
Polycystic ovarian syndrome (PCOS) is a "multispeciality" disorder suspected in patients with irregular menses and clinical signs of hyperandrogenism such as acne, seborrhoea, hirsutism, irregular menses, infertility, and alopecia. Recently, PCOS has been associated with the metabolic syndrome. Patients may develop obesity, insulin resistance, acanthosis nigricans, Type 2 diabetes, dyslipidemias, hypertension, non-alcoholic liver disease, and obstructive sleep apnoea. Good clinical examination with hematological and radiological investigations is required for clinical evaluation. Management is a combined effort involving a dermatologist, endocrinologist, gynecologist, and nutritionist. Morbidity in addition includes a low "self image" and poor quality of life. Long term medications and lifestyle changes are essential for a successful outcome. This article focuses on understanding the normal and abnormal endocrine functions involved in the pathogenesis of PCOS. Proper diagnosis and management of the patient is discussed.
“…It was also noted that brothers of the patients with PCOS had increased levels of DHEAS when compared with age matched controls. [13] Fathers of adolescent girls have a very high incidence of obesity (94%) and metabolic syndrome (79%). Also, mothers of such patients tend to be obese (54.4%) or overweight (11.4%) with the incidence of metabolic syndrome being 34%.…”
Polycystic ovarian syndrome (PCOS) is a "multispeciality" disorder suspected in patients with irregular menses and clinical signs of hyperandrogenism such as acne, seborrhoea, hirsutism, irregular menses, infertility, and alopecia. Recently, PCOS has been associated with the metabolic syndrome. Patients may develop obesity, insulin resistance, acanthosis nigricans, Type 2 diabetes, dyslipidemias, hypertension, non-alcoholic liver disease, and obstructive sleep apnoea. Good clinical examination with hematological and radiological investigations is required for clinical evaluation. Management is a combined effort involving a dermatologist, endocrinologist, gynecologist, and nutritionist. Morbidity in addition includes a low "self image" and poor quality of life. Long term medications and lifestyle changes are essential for a successful outcome. This article focuses on understanding the normal and abnormal endocrine functions involved in the pathogenesis of PCOS. Proper diagnosis and management of the patient is discussed.
“…Finally, affected male relatives, while demonstrating evidence of androgen excess (34) and insulin resistance (35), do not demonstrate obvious impairment in fertility or ability to attract a suitable partner and in ancient times would even have had the metabolic advantages of PCOS females, and thus were readily able to transmit susceptibility alleles. Consequently, the metabolic and physical advantages of affected women and their progeny, the rearing advantages of their family units, the heterogeneity of the phenotype and genotype, and ready transmissibility of the genotype by affected males could have potentially equalized any disadvantages arising from the overall lower number of children begotten by PCOS women.…”
Section: Polycystic Ovary Syndrome: An Ancient Disorder?mentioning
PCOS appears to be an ancient disorder, which persisted in human evolution despite reduced fecundity because of benefits to affected women such as greater sturdiness and improved energy utilization, a rearing advantage for their children and kin, and a reduction in the risk of perinatal mortality. This raises the possibility that gene variants eventually found to be associated with PCOS will be similar across ethnic groups and races.
“…Brothers of women with PCOS have significantly higher DHEAS levels compared to controls suggesting an inherited abnormality in adrenal androgen secretion. 20 However, in PCOS, no genetic alterations of adrenal enzymatic activity have been found 21 and the most consistent abnormality is an increased adrenal androgen response to adrenocorticotropin hormone (ACTH). [22][23][24] Because circulating ACTH is normal, 22 it is probable that factors external to the adrenal gland are responsible for the increased adrenal androgen responsivity.…”
Because in normal women androgens are secreted in almost equal quantities by both adrenals and ovaries, for many years many studies have tried to distinguish the source of androgen excess. However, in the last 10-15 years, the diagnoses of ovarian or adrenal hyperandrogenism have almost disappeared. This is due to the lack of specificity of dynamic tests as well as to the emphasis given on clinical information and ovarian sonography for the diagnosis of hyperandrogenic syndromes. However, determination of the source of increased androgens may still be useful for improving the classification and the understanding of androgen excess disorders. The aim of this review is to examine the source of androgen excess in the three more common androgen excess disorders: polycystic ovary syndrome (PCOS), idiopathic hyperandrogenism; and nonclassic 21-hydroxylase deficiency (NCAH). The ovary is the main androgen source in PCOS and idiopathic hyperandrogenism while adrenal androgen secretion is prevalent in NCAH. However, androgen secretion from more than one source is common in all main forms of hyperandrogenism as is the case in 70-80% of patients with NCAH, in 35% of women with PCOS, and in 50% of patients with idiopathic hyperandrogenism. Secondary PCOS is the main cause of ovarian androgen excess in nonclassic 21-hydroxylase deficiency while adrenal hyperandrogenism in PCOS and idiopathic hyperandrogenism is probably the consequence of multiple factors including hyperinsulinemia, altered cortisol metabolism, and increased ovarian steroid production. The clinical image is not generally affected by the source of androgen excess. However, hyperandrogenic patients with increased dehydroepiandrosterone sulfate (DHEAS) tend to have lower body weight and insulin levels and a better metabolic profile.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.